Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model

Background and aims: Previous work has shown that oral losartan can enhance microfracture-mediated cartilage repair in a rabbit osteochondral defect injury model. In this study, we aimed to determine whether oral losartan would have a detrimental effect on articular cartilage and bone homeostasis in...

Full description

Bibliographic Details
Main Authors: Zhenhan Deng, Xueqin Gao, Hajime Utsunomiya, Justin W. Arner, Joseph J. Ruzbarsky, Matthieu Huard, Sudheer Ravuri, Marc J. Philippon, Johnny Huard
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Bone Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352187222003606
_version_ 1828332713393782784
author Zhenhan Deng
Xueqin Gao
Hajime Utsunomiya
Justin W. Arner
Joseph J. Ruzbarsky
Matthieu Huard
Sudheer Ravuri
Marc J. Philippon
Johnny Huard
author_facet Zhenhan Deng
Xueqin Gao
Hajime Utsunomiya
Justin W. Arner
Joseph J. Ruzbarsky
Matthieu Huard
Sudheer Ravuri
Marc J. Philippon
Johnny Huard
author_sort Zhenhan Deng
collection DOAJ
description Background and aims: Previous work has shown that oral losartan can enhance microfracture-mediated cartilage repair in a rabbit osteochondral defect injury model. In this study, we aimed to determine whether oral losartan would have a detrimental effect on articular cartilage and bone homeostasis in the uninjured sides. Methods: New Zealand rabbits were divided into 4 groups including normal uninjured (Normal), contralateral uninjured side of osteochondral defect (Defect), osteochondral defect plus microfracture (Microfracture) and osteochondral defect plus microfracture and losartan oral administration (10 mg/kg/day) (Losartan). Rabbits underwent different surgeries and treatment and were sacrificed at 12 weeks. Both side of the normal group and uninjured side of treatment groups tibias were harvested for Micro-CT and histological analysis for cartilage and bone including H&E staining, Herovici's staining (bone and cartilage) Alcian blue and Safranin O staining (cartilage) as well as immunohistochemistry of losartan related signaling pathways molecules for both cartilage and bone. Results: Our results showed losartan oral treatment at 10 mg/kg/day slightly increase Alcian blue positive matrix as well as decrease collagen type 3 in articular cartilage while having no significant effect on articular cartilage structure, cellularity, and other matrix. Losartan treatment also did not affect angiotensin receptor type 1 (AGTR1), angiotensin receptor type 2 (AGTR2) and phosphorylated transforming factor β1 activated kinase 1 (pTAK1) expression level and pattern in the articular cartilage. Furthermore, losartan treatment did not affect microarchitecture of normal cancellous bone and cortical bone of tibias compared to normal and other groups. Losartan treatment slightly increased osteocalcin positive osteoblasts on the surface of cancellous bone and did not affect bone matrix collagen type 1 content and did not change AGTR1, AGTR2 and pTAK1 signal molecule expression. Conclusion: Oral losartan used as a microfracture augmentation therapeutic does not have significant effect on uninjured articular cartilage and bone based on our preclinical rabbit model. These results provided further evidence that the current regimen of using losartan as a microfracture augmentation therapeutic is safe with respect to bone and cartilage homeostasis and support clinical trials for its application in human cartilage repair.
first_indexed 2024-04-13T21:10:02Z
format Article
id doaj.art-0242b331d96d40f58cb59af92f991d5d
institution Directory Open Access Journal
issn 2352-1872
language English
last_indexed 2024-04-13T21:10:02Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Bone Reports
spelling doaj.art-0242b331d96d40f58cb59af92f991d5d2022-12-22T02:29:51ZengElsevierBone Reports2352-18722022-06-0116101526Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit modelZhenhan Deng0Xueqin Gao1Hajime Utsunomiya2Justin W. Arner3Joseph J. Ruzbarsky4Matthieu Huard5Sudheer Ravuri6Marc J. Philippon7Johnny Huard8Department of Orthopaedic Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USADepartment of Orthopaedic Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA; Steadman Philippon Research Institute, Vail, CO, USA; Correspondence to: X. Gao, Center for Regenerative Sports Medicine Fort Collins Laboratory, Steadman Philippon Research Institute, 702 W Drake Road, G101, Fort Collins, CO 80526, USA.Steadman Philippon Research Institute, Vail, CO, USASteadman Philippon Research Institute, Vail, CO, USASteadman Philippon Research Institute, Vail, CO, USA; The Steadman Clinic, Aspen, CO, USASteadman Philippon Research Institute, Vail, CO, USASteadman Philippon Research Institute, Vail, CO, USASteadman Philippon Research Institute, Vail, CO, USADepartment of Orthopaedic Surgery, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA; Steadman Philippon Research Institute, Vail, CO, USA; Correspondence to: J. Huard, The Steadman Philippon Research Institute, 181 West Meadow Drive, Suite 1000, Vail, CO 81657, USA.Background and aims: Previous work has shown that oral losartan can enhance microfracture-mediated cartilage repair in a rabbit osteochondral defect injury model. In this study, we aimed to determine whether oral losartan would have a detrimental effect on articular cartilage and bone homeostasis in the uninjured sides. Methods: New Zealand rabbits were divided into 4 groups including normal uninjured (Normal), contralateral uninjured side of osteochondral defect (Defect), osteochondral defect plus microfracture (Microfracture) and osteochondral defect plus microfracture and losartan oral administration (10 mg/kg/day) (Losartan). Rabbits underwent different surgeries and treatment and were sacrificed at 12 weeks. Both side of the normal group and uninjured side of treatment groups tibias were harvested for Micro-CT and histological analysis for cartilage and bone including H&E staining, Herovici's staining (bone and cartilage) Alcian blue and Safranin O staining (cartilage) as well as immunohistochemistry of losartan related signaling pathways molecules for both cartilage and bone. Results: Our results showed losartan oral treatment at 10 mg/kg/day slightly increase Alcian blue positive matrix as well as decrease collagen type 3 in articular cartilage while having no significant effect on articular cartilage structure, cellularity, and other matrix. Losartan treatment also did not affect angiotensin receptor type 1 (AGTR1), angiotensin receptor type 2 (AGTR2) and phosphorylated transforming factor β1 activated kinase 1 (pTAK1) expression level and pattern in the articular cartilage. Furthermore, losartan treatment did not affect microarchitecture of normal cancellous bone and cortical bone of tibias compared to normal and other groups. Losartan treatment slightly increased osteocalcin positive osteoblasts on the surface of cancellous bone and did not affect bone matrix collagen type 1 content and did not change AGTR1, AGTR2 and pTAK1 signal molecule expression. Conclusion: Oral losartan used as a microfracture augmentation therapeutic does not have significant effect on uninjured articular cartilage and bone based on our preclinical rabbit model. These results provided further evidence that the current regimen of using losartan as a microfracture augmentation therapeutic is safe with respect to bone and cartilage homeostasis and support clinical trials for its application in human cartilage repair.http://www.sciencedirect.com/science/article/pii/S2352187222003606LosartanBoneArticular cartilageMicrofractureHomeostasis
spellingShingle Zhenhan Deng
Xueqin Gao
Hajime Utsunomiya
Justin W. Arner
Joseph J. Ruzbarsky
Matthieu Huard
Sudheer Ravuri
Marc J. Philippon
Johnny Huard
Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
Bone Reports
Losartan
Bone
Articular cartilage
Microfracture
Homeostasis
title Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
title_full Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
title_fullStr Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
title_full_unstemmed Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
title_short Effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
title_sort effects of oral losartan administration on homeostasis of articular cartilage and bone in a rabbit model
topic Losartan
Bone
Articular cartilage
Microfracture
Homeostasis
url http://www.sciencedirect.com/science/article/pii/S2352187222003606
work_keys_str_mv AT zhenhandeng effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT xueqingao effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT hajimeutsunomiya effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT justinwarner effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT josephjruzbarsky effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT matthieuhuard effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT sudheerravuri effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT marcjphilippon effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel
AT johnnyhuard effectsoforallosartanadministrationonhomeostasisofarticularcartilageandboneinarabbitmodel